Filed: 8/14/2024ACC: 0000895345-24-000350
📋 What this filing means
ALERCE INVESTMENT MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $51.02M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$51.02M
Total AUM (reported)
25.47M
Total Shares
Allocation by class
COM$44.53M87.3%
CL A$3.40M6.7%
SPONSORED ADS$3.08M6.0%
Portfolio Concentration
Top 3$45.55M89.3%
4–10$5.46M10.7%
Top 3 weight
89.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 25.47M
Sole
Full voting authority
25.47M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
ANNEXON INC
SOLEShares7.41M
TypeSH
Market value$36.29M
71.13%
Sole
7.41M
Shared
0.00
None
0.00
AKEBIA THERAPEUTICS INC
SOLEShares5.75M
TypeSH
Market value$5.86M
11.49%
Sole
5.75M
Shared
0.00
None
0.00
AMERICAN WELL CORP
SOLEShares10.48M
TypeSH
Market value$3.40M
6.67%
Sole
10.48M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares213K
TypeSH
Market value$3.08M
6.04%
Sole
213K
Shared
0.00
None
0.00
AADI BIOSCIENCE INC
SOLEShares1.63M
TypeSH
Market value$2.38M
4.67%
Sole
1.63M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ANNEXON INCSOLE | COM | 7.41M | SH | $36.29M 71.13% | 7.41M | 0.00 | 0.00 |
AKEBIA THERAPEUTICS INCSOLE | COM | 5.75M | SH | $5.86M 11.49% | 5.75M | 0.00 | 0.00 |
AMERICAN WELL CORPSOLE | CL A | 10.48M | SH | $3.40M 6.67% | 10.48M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 213K | SH | $3.08M 6.04% | 213K | 0.00 | 0.00 |
AADI BIOSCIENCE INCSOLE | COM | 1.63M | SH | $2.38M 4.67% | 1.63M | 0.00 | 0.00 |